The goal of this project is to develop new tools that would enable reprogramming multiple genes simultaneously and reduce transcriptional heterogeneity in cancer cells, which can significantly enhance the efficacy of the existing chemo- and immunotherapies against solid cancers.
|Effective start/end date||4/9/18 → 3/31/23|
- National Cancer Institute (5R01CA228272-05 REVISED)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.